Free tool
Stocks above their 200-day average
We cover 415 companies trading above their own 200-day average. The median market value in the group is $65.40M. Across the group, the median move over the past trading day is 0.00%. 100% of the 415 with a 200-day average trade above it. Price change over the past year runs from −29.3% to +131.4% across the middle 80 percent of the group, with a median of +16.9%.
Other lists in this group
Table
415 of 10,735 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| ABTT34.SA | Abbott Laboratories | $199.23B | Large cap | −16.35% |
| ABT | Abbott Laboratories | $198.74B | Large cap | −11.83% |
| GILD | Gilead Sciences, Inc. | $184.47B | Large cap | +32.51% |
| GIS.DE | Gilead Sciences, Inc. | $184.35B | Large cap | +33.64% |
| PFIZ34.SA | Pfizer Inc. | $161.53B | Large cap | +11.58% |
| PFE | Pfizer Inc. | $161.30B | Large cap | +18.72% |
| PFE.DE | Pfizer Inc. | $161.11B | Large cap | +22.96% |
| DHER34.SA | Danaher Corporation | $151.72B | Large cap | +0.89% |
| DAP.DE | Danaher Corporation | $151.59B | Large cap | +6.90% |
| DHR | Danaher Corporation | $151.40B | Large cap | +5.61% |
| VX1.DE | Vertex Pharmaceuticals Incorporated | $139.82B | Large cap | +41.64% |
| BMYB34.SA | Bristol-Myers Squibb Company | $138.65B | Large cap | +40.74% |
| VRTX | Vertex Pharmaceuticals Incorporated | $138.63B | Large cap | +40.66% |
| BMY | Bristol-Myers Squibb Company | $138.03B | Large cap | +47.01% |
| BRM.DE | Bristol-Myers Squibb Company | $137.92B | Large cap | +50.84% |
| MDT | Medtronic plc | $117.78B | Large cap | +2.29% |
| 2M6.DE | Medtronic plc | $117.57B | Large cap | +2.65% |
| MCK | McKesson Corporation | $104.54B | Large cap | +31.57% |
| ELV | Elevance Health, Inc. | $87.30B | Large cap | +32.12% |
| E1LV34.SA | Elevance Health, Inc. | $86.53B | Large cap | +21.66% |
| REGN34.SA | Regeneron Pharmaceuticals, Inc. | $85.16B | Large cap | +33.80% |
| REGN | Regeneron Pharmaceuticals, Inc. | $83.89B | Large cap | +39.36% |
| CI | The Cigna Group | $74.22B | Large cap | −4.84% |
| MRK.DE | Merck KGaA | $70.28B | Large cap | +32.17% |
| ARGX | argenx SE | $65.51B | Large cap | +47.90% |
| M1RN34.SA | Moderna, Inc. | $63.51B | Large cap | +462.13% |
| A1RG34.SA | argenx SE | $63.16B | Large cap | +36.97% |
| COR | Cencora, Inc. | $62.55B | Large cap | +13.45% |
| MRNA | Moderna, Inc. | $59.75B | Large cap | +496.25% |
| CSL.AX | CSL Limited | $59.72B | Large cap | −16.37% |
| 0QF.DE | Moderna, Inc. | $59.07B | Large cap | +550.51% |
| TAK | Takeda Pharmaceutical Company Limited | $58.60B | Large cap | +22.68% |
| 4502.T | Takeda Pharmaceutical Company Limited | $58.08B | Large cap | +36.03% |
| TAKP34.SA | Takeda Pharmaceutical Company Limited | $57.22B | Large cap | +18.03% |
| BAYN.DE | Bayer Aktiengesellschaft | $56.25B | Large cap | +76.91% |
| BAY.WA | Bayer Aktiengesellschaft | $55.90B | Large cap | +76.59% |
| C1AH34.SA | Cardinal Health, Inc. | $55.77B | Large cap | +52.41% |
| CAH | Cardinal Health, Inc. | $55.45B | Large cap | +61.05% |
| EWL.DE | Edwards Lifesciences Corporation | $52.39B | Large cap | +11.65% |
| EW | Edwards Lifesciences Corporation | $52.32B | Large cap | +12.21% |
| BOX.DE | Becton, Dickinson and Company | $51.84B | Large cap | +1.73% |
| BDX | Becton, Dickinson and Company | $51.81B | Large cap | +25.97% |
| B1DX34.SA | Becton, Dickinson and Company | $51.78B | Large cap | −113.87% |
| SHL.DE | Siemens Healthineers AG | $51.23B | Large cap | −14.18% |
| NTRA | Natera, Inc. | $48.53B | Large cap | +107.59% |
| HUM | Humana Inc. | $46.96B | Large cap | +33.14% |
| H1UM34.SA | Humana Inc. | $46.72B | Large cap | +24.36% |
| RVMD | Revolution Medicines, Inc. | $46.18B | Large cap | +466.35% |
| H6D0.DE | Haleon plc | $44.85B | Large cap | +5.39% |
| HLN | Haleon plc | $44.72B | Large cap | +6.13% |
| HLN.L | Haleon plc | $44.62B | Large cap | +2.68% |
| T1EV34.SA | Teva Pharmaceutical Industries Limited | $44.24B | Large cap | +94.70% |
| TEVA | Teva Pharmaceutical Industries Limited | $44.19B | Large cap | +110.08% |
| A | Agilent Technologies, Inc. | $43.80B | Large cap | +31.46% |
| IQV | IQVIA Holdings Inc. | $43.04B | Large cap | +38.51% |
| QTS.DE | IQVIA Holdings Inc. | $43.01B | Large cap | −4.04% |
| ONC | BeOne Medicines AG | $42.58B | Large cap | +25.21% |
| V2EE34.SA | Veeva Systems Inc. | $41.01B | Large cap | −18.65% |
| WAT | Waters Corporation | $40.67B | Large cap | +40.57% |
| 4578.T | Otsuka Holdings Co., Ltd. | $40.39B | Large cap | +57.62% |
| VEE.DE | Veeva Systems Inc. | $40.02B | Large cap | +13.43% |
| VEEV | Veeva Systems Inc. | $39.78B | Large cap | −16.58% |
| WATC34.SA | Waters Corporation | $36.35B | Large cap | +24.76% |
| RPRX | Royalty Pharma plc | $35.71B | Large cap | +74.00% |
| RMD | ResMed Inc. | $34.13B | Large cap | −15.77% |
| I1LM34.SA | Illumina, Inc. | $34.10B | Large cap | +113.13% |
| ILU.DE | Illumina, Inc. | $34.08B | Large cap | +129.80% |
| ILMN | Illumina, Inc. | $33.95B | Large cap | +125.88% |
| D1EX34.SA | DexCom, Inc. | $33.75B | Large cap | +9.64% |
| DXCM | DexCom, Inc. | $33.65B | Large cap | +16.47% |
| DC4.DE | DexCom, Inc. | $33.35B | Large cap | +21.06% |
| GEHC | GE HealthCare Technologies Inc. | $33.35B | Large cap | −1.15% |
| BIIB | Biogen Inc. | $32.66B | Large cap | +62.12% |
| C1NC34.SA | Centene Corporation | $32.65B | Large cap | +116.61% |
| BIIB34.SA | Biogen Inc. | $32.56B | Large cap | +47.86% |
| IDP.DE | Biogen Inc. | $32.39B | Large cap | +65.32% |
| CNC | Centene Corporation | $32.34B | Large cap | +127.01% |
| FRE.DE | Fresenius SE & Co. KGaA | $30.43B | Large cap | +1.64% |
| B1NT34.SA | BioNTech SE | $28.32B | Large cap | +2.68% |
| BNTX | BioNTech SE | $28.28B | Large cap | +9.27% |
| 22UA.DE | BioNTech SE | $28.28B | Large cap | +14.09% |
| MTD | Mettler-Toledo International Inc. | $28.10B | Large cap | +8.81% |
| MTO.DE | Mettler-Toledo International Inc. | $27.92B | Large cap | +13.15% |
| LH | Labcorp Holdings Inc. | $27.39B | Large cap | +21.14% |
| DGX | Quest Diagnostics Incorporated | $26.99B | Large cap | +38.12% |
| 4503.T | Astellas Pharma Inc. | $26.88B | Large cap | +53.57% |
| ROIV | Roivant Sciences Ltd. | $26.55B | Large cap | +206.51% |
| INCY | Incyte Corporation | $25.97B | Large cap | +51.01% |
| I1NC34.SA | Incyte Corporation | $25.83B | Large cap | +41.91% |
| WST | West Pharmaceutical Services, Inc. | $24.63B | Large cap | +42.61% |
| 4543.T | Terumo Corporation | $23.67B | Large cap | −2.68% |
| STE | STERIS plc | $23.09B | Large cap | −4.41% |
| GH | Guardant Health, Inc. | $22.94B | Large cap | +169.17% |
| THC | Tenet Healthcare Corporation | $21.89B | Large cap | +50.70% |
| DIM.PA | Sartorius Stedim Biotech S.A. | $21.78B | Large cap | +11.64% |
| 56S1.DE | Sartorius Stedim Biotech S.A. | $21.77B | Large cap | +11.32% |
| GMAB | Genmab A/S | $21.42B | Large cap | +36.20% |
| GMAB.CO | Genmab A/S | $20.69B | Large cap | +36.19% |
| GE9.DE | Genmab A/S | $20.65B | Large cap | −11.12% |
| SRT3.DE | Sartorius Aktiengesellschaft | $19.68B | Large cap | +25.88% |
| VIA.DE | Viatris Inc. | $19.41B | Large cap | +67.32% |
| VTRS | Viatris Inc. | $19.35B | Large cap | +66.19% |
| ZBH | Zimmer Biomet Holdings, Inc. | $19.34B | Large cap | −4.32% |
| Z1BH34.SA | Zimmer Biomet Holdings, Inc. | $18.07B | Large cap | −5.04% |
| MEDP | Medpace Holdings, Inc. | $17.28B | Large cap | +30.74% |
| SOBI.ST | Swedish Orphan Biovitrum AB (publ) | $16.99B | Large cap | +61.26% |
| JAZZ | Jazz Pharmaceuticals plc | $16.89B | Large cap | +100.35% |
| ASND | Ascendis Pharma A/S | $16.41B | Large cap | +29.66% |
| IPN.PA | Ipsen S.A. | $15.97B | Large cap | +40.80% |
| NBIX | Neurocrine Biosciences, Inc. | $15.92B | Large cap | +13.36% |
| N1BI34.SA | Neurocrine Biosciences, Inc. | $15.65B | Large cap | +7.37% |
| SOLV | Solventum Corporation | $15.58B | Large cap | +25.57% |
| SRT.DE | Sartorius Aktiengesellschaft | $15.54B | Large cap | +21.79% |
| BBIO | BridgeBio Pharma, Inc. | $15.52B | Large cap | +60.05% |
| FPH.AX | Fisher & Paykel Healthcare Corporation Limited | $15.44B | Large cap | +11.27% |
| C1OO34.SA | The Cooper Companies, Inc. | $15.12B | Large cap | −0.89% |
| ESF0.DE | Eurofins Scientific SE | $14.67B | Large cap | +12.65% |
| ERF.PA | Eurofins Scientific SE | $14.64B | Large cap | +15.60% |
| 7733.T | Olympus Corporation | $14.46B | Large cap | +27.06% |
| CRL | Charles River Laboratories International, Inc. | $14.09B | Large cap | +81.27% |
| EXEL | Exelixis, Inc. | $14.05B | Large cap | +45.68% |
| RVTY | Revvity, Inc. | $13.93B | Large cap | +42.93% |
| BAX | Baxter International Inc. | $13.70B | Large cap | +8.90% |
| PME.AX | Pro Medicus Limited | $13.66B | Large cap | −39.15% |
| B1AX34.SA | Baxter International Inc. | $13.60B | Large cap | +3.61% |
| ORNBV.HE | Orion Oyj | $13.16B | Large cap | +21.01% |
| ORNAV.HE | Orion Oyj | $13.11B | Large cap | +21.27% |
| ICLR | ICON Public Limited Company | $13.03B | Large cap | −2.91% |
| CORT | Corcept Therapeutics Incorporated | $12.95B | Large cap | +71.81% |
| PEN | Penumbra, Inc. | $12.72B | Large cap | +21.02% |
| BMRN | BioMarin Pharmaceutical Inc. | $12.70B | Large cap | +11.85% |
| FME.DE | Fresenius Medical Care AG | $12.64B | Large cap | −2.61% |
| REC.MI | Recordati Industria Chimica e Farmaceutica S.p.A. | $12.57B | Large cap | +1.80% |
| B1MR34.SA | BioMarin Pharmaceutical Inc. | $12.54B | Large cap | +4.97% |
| ELAN | Elanco Animal Health Incorporated | $12.53B | Large cap | +35.64% |
| ARWR | Arrowhead Pharmaceuticals, Inc. | $12.52B | Large cap | +308.99% |
| FMS | Fresenius Medical Care AG | $12.51B | Large cap | −3.21% |
| R1VT34.SA | Revvity, Inc. | $12.50B | Large cap | +22.81% |
| MDGL | Madrigal Pharmaceuticals, Inc. | $12.45B | Large cap | +26.78% |
| HALO | Halozyme Therapeutics, Inc. | $12.41B | Large cap | +46.30% |
| TEM | Tempus AI, Inc. | $12.40B | Large cap | −6.49% |
| EHC | Encompass Health Corporation | $11.92B | Large cap | −1.75% |
| DVAI34.SA | DaVita Inc. | $11.70B | Large cap | +18.80% |
| T1CH34.SA | Bio-Techne Corporation | $11.51B | Large cap | +23.42% |
| DVA | DaVita Inc. | $11.41B | Large cap | +30.89% |
| TECH | Bio-Techne Corporation | $11.35B | Large cap | +29.33% |
| BTSG | BrightSpring Health Services, Inc. | $11.32B | Large cap | +156.37% |
| CYTK | Cytokinetics, Incorporated | $11.01B | Large cap | +109.36% |
| AXSM | Axsome Therapeutics, Inc. | $10.85B | Large cap | +69.99% |
| GKOS | Glaukos Corporation | $10.65B | Large cap | +89.83% |
| KRYS | Krystal Biotech, Inc. | $10.65B | Large cap | +143.67% |
| MOH | Molina Healthcare, Inc. | $10.57B | Large cap | +13.35% |
| PRAX | Praxis Precision Medicines, Inc. | $10.54B | Large cap | +704.28% |
| KYMR | Kymera Therapeutics, Inc. | $10.53B | Large cap | +197.09% |
| BIO | Bio-Rad Laboratories, Inc. | $10.40B | Large cap | +32.71% |
| HSIC | Henry Schein, Inc. | $10.30B | Large cap | +31.02% |
| RGEN | Repligen Corporation | $10.25B | Large cap | +51.67% |
| APGE | Apogee Therapeutics, Inc. | $10.21B | Large cap | +257.11% |
| NANOFH.HE | Nanoform Finland Oyj | $95.78M | Micro cap | +15.66% |
| ILA.AX | Island Pharmaceuticals Limited | $95.70M | Micro cap | +109.30% |
| 004080.KS | Shinhung Co., Ltd | $94.21M | Micro cap | +2.54% |
| ATRA | Atara Biotherapeutics, Inc. | $94.15M | Micro cap | −24.05% |
| NANOFS.ST | Nanoform Finland Oyj | $93.63M | Micro cap | +19.56% |
| ACRV | Acrivon Therapeutics, Inc. | $93.42M | Micro cap | +52.94% |
| BIOPOR.CO | BioPorto A/S | $93.40M | Micro cap | −3.13% |
| ECOR | electroCore, Inc. | $93.31M | Micro cap | +86.49% |
| IBT-B.ST | Infant Bacterial Therapeutics AB (publ) | $91.93M | Micro cap | +15.88% |
| ICCC | ImmuCell Corporation | $91.00M | Micro cap | +64.26% |
| 366A.T | WELLNESS COMMUNICATIONS CORPORA | $89.79M | Micro cap | −23.84% |
| EAH.L | ECO Animal Health Group plc | $89.77M | Micro cap | +34.69% |
| RLYB | Rallybio Corporation | $89.64M | Micro cap | +257.63% |
| 194A.T | WOLVES HAND CO LTD | $88.72M | Micro cap | +102.92% |
| NANEXA.ST | Nanexa AB (publ) | $87.59M | Micro cap | +100.43% |
| ATHE | Alterity Therapeutics Limited | $86.64M | Micro cap | −4.40% |
| ALZCUR.ST | AlzeCure Pharma AB (publ) | $86.56M | Micro cap | +78.27% |
| BB1.AX | BLINKLAB FPO [BB1] | $86.46M | Micro cap | +47.22% |
| CREO.L | Creo Medical Group PLC | $85.82M | Micro cap | −1.90% |
| CING | Cingulate Inc. | $85.36M | Micro cap | +29.19% |
| 7792.T | Colan Totte.Co.,Ltd. | $84.83M | Micro cap | +6.32% |
| ACET | Adicet Bio, Inc. | $83.79M | Micro cap | −26.01% |
| POLB.L | Poolbeg Pharma PLC | $82.41M | Micro cap | +164.62% |
| HIGH.DE | Cantourage Group SE | $81.55M | Micro cap | +51.90% |
| OBI.L | Ondine Biomedical Inc. | $81.20M | Micro cap | −24.19% |
| INIFY.OL | INIFY Laboratories AB | $81.09M | Micro cap | +44.55% |
| ATH.AX | Alterity Therapeutics Limited | $80.50M | Micro cap | −14.17% |
| APLM | Apollomics, Inc. | $76.75M | Micro cap | +320.55% |
| OSTX | OS Therapies Incorporated | $76.68M | Micro cap | −34.00% |
| LONA | LeonaBio, Inc. | $75.47M | Micro cap | +95.25% |
| NRXS | NeurAxis, Inc. | $74.84M | Micro cap | +146.28% |
| MNOV | MediciNova, Inc. | $72.85M | Micro cap | +10.45% |
| KOO.L | Kooth plc | $72.00M | Micro cap | −7.59% |
| FBIOP | Fortress Biotech, Inc. | $71.45M | Micro cap | +131.74% |
| ALTHX.PA | THX Pharma Société Anonyme | $71.22M | Micro cap | +73.96% |
| 4875.T | MediciNova, Inc. | $71.04M | Micro cap | +11.17% |
| 7702.T | JMS Co.,Ltd. | $70.66M | Micro cap | +6.20% |
| ZLNA.OL | Zelluna ASA | $70.31M | Micro cap | +56.57% |
| SAR.L | Sareum Holdings plc | $70.10M | Micro cap | +76.19% |
| PMVP | PMV Pharmaceuticals, Inc. | $70.03M | Micro cap | −7.75% |
| INCR | InterCure Ltd. | $69.65M | Micro cap | +265.03% |
| 9341.T | GENOVA, Inc. | $68.87M | Micro cap | +1.56% |
| INMB | INmune Bio Inc. | $67.86M | Micro cap | +19.56% |
| RNXT | RenovoRx, Inc. | $67.24M | Micro cap | +61.08% |
| 4512.T | Wakamoto Pharmaceutical Co.,Ltd. | $67.16M | Micro cap | +1.97% |
| SER | Serina Therapeutics, Inc. | $66.80M | Micro cap | −47.29% |
| AVE.AX | Avecho Biotechnology Limited | $66.64M | Micro cap | +300.00% |
| BOLD | Boundless Bio, Inc. | $66.31M | Micro cap | +155.70% |
| 2934.T | J Frontier Co.,Ltd. | $65.60M | Micro cap | −2.11% |
| TLPH | Talphera, Inc. | $65.40M | Micro cap | +133.33% |
| R0L.F | J Frontier Co.,Ltd. | $64.05M | Micro cap | −44.02% |
| MYO | Myomo, Inc. | $60.60M | Micro cap | +36.61% |
| INKT | MiNK Therapeutics, Inc. | $60.16M | Micro cap | −26.22% |
| 9265.T | Yamashita Health Care Holdings,Inc. | $59.83M | Micro cap | +24.40% |
| XLO | Xilio Therapeutics, Inc. | $59.55M | Micro cap | −5.63% |
| 7133.T | HYUGA PRIMARY CARE Co.,Ltd. | $57.90M | Micro cap | −0.72% |
| 4524.T | Morishita Jintan Co., Ltd. | $57.77M | Micro cap | +4.22% |
| COCH | Envoy Medical, Inc. | $56.82M | Micro cap | −37.09% |
| 4896.T | K Pharma,Inc. | $56.45M | Micro cap | +14.56% |
| SCYX | SCYNEXIS, Inc. | $56.41M | Micro cap | +579.04% |
| ALTHE.PA | Theraclion SA | $55.29M | Micro cap | −22.30% |
| ALSMA.PA | S.M.A.I.O S.A. | $54.96M | Micro cap | +14.29% |
| NTRB | Nutriband Inc. | $54.70M | Micro cap | −29.80% |
| PRPO | Precipio, Inc. | $54.43M | Micro cap | +99.25% |
| ATX.AX | Amplia Therapeutics Limited | $54.23M | Micro cap | −14.71% |
| EPIS-B.ST | Episurf Medical AB (publ) | $53.85M | Micro cap | +71.52% |
| OHGR.L | One Health Group Plc | $53.82M | Micro cap | +17.03% |
| 4572.T | Carna Biosciences, Inc. | $53.63M | Micro cap | +81.90% |
| MOB.ST | Moberg Pharma AB (publ) | $53.40M | Micro cap | +32.92% |
| 9218.T | Mental Health Technologies Co.,Ltd. | $51.69M | Micro cap | −7.41% |
| 4597.T | Solasia Pharma K.K. | $51.40M | Micro cap | −18.92% |
| ENP.AX | Entropy Neurodynamics Limited | $48.13M | Micro cap | +10.81% |
| HOWL | Werewolf Therapeutics, Inc. | $48.05M | Micro cap | −25.65% |
| MLSS | Milestone Scientific Inc. | $47.87M | Micro cap | −10.10% |
| 3628.T | Data Horizon Co.,Ltd. | $47.15M | Micro cap | +7.64% |
| ALGS | Aligos Therapeutics, Inc. | $46.65M | Micro cap | −33.72% |
| IMMU.ST | Mendus AB (publ) | $46.19M | Micro cap | −4.57% |
| CLBIO.ST | Corline Biomedical AB | $45.27M | Micro cap | +45.56% |
| ELUT | Elutia Inc. | $44.29M | Micro cap | −54.75% |
| 9340.T | ASO International, Inc. | $44.19M | Micro cap | +0.18% |
| NEPH | Nephros, Inc. | $43.98M | Micro cap | 0.00% |
| CTE.AX | Cryosite Limited | $43.85M | Micro cap | +56.25% |
| ONCIN.OL | Oncoinvent ASA | $43.71M | Micro cap | +10.90% |
| ALCOX.PA | Nicox S.A. | $43.02M | Micro cap | +2.70% |
| ALNOV.PA | Novacyt S.A. | $42.69M | Micro cap | +7.38% |
| NCYT.L | Novacyt S.A. | $42.07M | Micro cap | +7.81% |
| 4893.T | Noile-Immune Biotech Inc. | $40.36M | Micro cap | −16.38% |
| 206A.T | PRISM BioLab Co.,LTD | $39.48M | Micro cap | −5.56% |
| 002630.KS | ORIENT BIO Inc. | $39.42M | Micro cap | +49.67% |
| PKY.AX | Pathkey.AI Ltd | $38.82M | Micro cap | +77.27% |
| IVACC.ST | Intervacc AB (publ) | $38.50M | Micro cap | +4.78% |
| 7980.T | Shigematsu Works Co., Ltd. | $38.11M | Micro cap | +6.69% |
| MVP.AX | Medical Developments International Limited | $37.65M | Micro cap | −19.83% |
| 7707.T | Precision System Science Co., Ltd. | $37.57M | Micro cap | +6.34% |
| 7681.T | LEOCLAN Co.,Ltd. | $37.16M | Micro cap | −10.99% |
| ALMKT.PA | Mauna Kea Technologies SA | $37.11M | Micro cap | +47.33% |
| ABDX.L | Abingdon Health Plc | $36.92M | Micro cap | +104.76% |
| 7091.T | Living Platform,Ltd. | $36.16M | Micro cap | +34.42% |
| SPRINT.ST | Sprint Bioscience AB (publ) | $35.56M | Micro cap | +458.51% |
| ALGEN.PA | genOway Société anonyme | $35.25M | Micro cap | −18.00% |
| BIOWKS.ST | Bio-Works Technologies AB (publ) | $35.21M | Micro cap | +4.75% |
| HBIO | Harvard Bioscience, Inc. | $34.83M | Micro cap | +44.34% |
| PTG.WA | Poltreg S.A. | $34.78M | Micro cap | −14.68% |
| CCEL | Cryo-Cell International, Inc. | $34.67M | Micro cap | −3.19% |
| NSYS | Nortech Systems Incorporated | $33.62M | Micro cap | +30.74% |
| KYNB | Kyntra Bio, Inc. | $32.82M | Micro cap | −22.66% |
| PXS.L | Provexis plc | $32.52M | Micro cap | +51.39% |
| 4172.T | Hi-CRATES CO.,LTD. | $32.39M | Micro cap | +3.74% |
| BRAIN.ST | BrainCool AB (publ) | $32.34M | Micro cap | −21.51% |
| SIGHT.PA | GenSight Biologics S.A. | $32.26M | Micro cap | −25.31% |
| RMTI | Rockwell Medical, Inc. | $31.90M | Micro cap | +438.44% |
| QNCX | Quince Therapeutics, Inc. | $31.84M | Micro cap | +100.71% |
| IGC | IGC Pharma, Inc. | $31.49M | Micro cap | −31.62% |
| ALDVI.PA | Advicenne S.A. | $30.93M | Micro cap | +39.11% |
| 4591.T | Ribomic Inc. | $30.52M | Micro cap | −17.31% |
| NXN.AX | Nexsen Ltd | $30.21M | Micro cap | −25.00% |
| MBX.TO | Microbix Biosystems Inc. | $30.10M | Micro cap | +27.08% |
| EYE.AX | Nova Eye Medical Limited | $29.60M | Micro cap | +3.45% |
| GDR.L | genedrive plc | $28.91M | Micro cap | +67.74% |
| BRNS | Barinthus Biotherapeutics plc | $28.86M | Micro cap | −38.04% |
| GRDX | GridAI Technologies Corp. | $28.75M | Micro cap | +111.52% |
| NN6.DE | NanoRepro AG | $27.65M | Micro cap | −4.90% |
| 6545.T | internet infinity Inc. | $27.61M | Micro cap | +34.23% |
| IRLAB-A.ST | IRLAB Therapeutics AB (publ) | $27.48M | Micro cap | −44.31% |
| SOFTX.OL | SoftOx Solutions AS | $27.33M | Micro cap | −15.04% |
| ISOFOL.ST | Isofol Medical AB (publ) | $26.92M | Micro cap | −1.87% |
| KLAR.ST | Klaria Pharma Holding AB (publ.) | $26.60M | Micro cap | +97.38% |
| TXMD | TherapeuticsMD, Inc. | $26.39M | Micro cap | +103.57% |
| OSL.AX | OncoSil Medical Limited | $25.86M | Micro cap | +0.87% |
| RENX.L | Renalytix Plc | $25.24M | Micro cap | −26.50% |
| INTEG-B.ST | Integrum AB (publ) | $24.72M | Micro cap | −79.55% |
| MRKR | Marker Therapeutics, Inc. | $24.18M | Micro cap | +54.26% |
| RUA.L | RUA Life Sciences plc | $24.04M | Micro cap | +130.93% |
| FEMY | Femasys Inc. | $23.87M | Micro cap | +711.11% |
| LABS.TO | MediPharm Labs Corp. | $23.16M | Micro cap | +6.67% |
| ALTAO.PA | Aton | $22.75M | Micro cap | +153.85% |
| BFRI | Biofrontera Inc. | $22.72M | Micro cap | +77.91% |
| 4884.T | Kringle Pharma, Inc. | $22.30M | Micro cap | −11.29% |
| RVP | Retractable Technologies, Inc. | $21.85M | Micro cap | −12.05% |
| COCP | Cocrystal Pharma, Inc. | $21.57M | Micro cap | −27.74% |
| CCM | Concord Medical Services Holdings Limited | $21.49M | Micro cap | −10.47% |
| ALLR | Allarity Therapeutics, Inc. | $21.32M | Micro cap | −15.72% |
| LFWD | Lifeward Ltd. | $20.93M | Micro cap | +0.03% |
| 7129.T | Miahelsa Holdings Corporation | $20.31M | Micro cap | +4.87% |
| RHT.AX | Resonance Health Limited | $20.23M | Micro cap | +43.90% |
| PMI | Picard Medical, Inc. | $20.13M | Micro cap | +113.51% |
| DEX.ST | Dextech Medical AB | $20.09M | Micro cap | +26.38% |
| NOX.AX | Noxopharm Limited | $19.87M | Micro cap | −10.00% |
| NCEL | NewcelX Ltd. | $19.52M | Micro cap | −84.77% |
| 9220.T | FB Care Service Co.,Ltd. | $19.37M | Micro cap | +11.55% |
| CLBX.L | CelLBxHealth plc | $19.30M | Micro cap | −79.17% |
| ALBIO.PA | Biosynex SA | $19.25M | Micro cap | −23.23% |
| VYNE | VYNE Therapeutics Inc | $19.07M | Micro cap | +8660.74% |
| 5619.T | MRSO INC | $18.85M | Micro cap | −16.43% |
| LEXX | Lexaria Bioscience Corp. | $18.24M | Micro cap | +1146.05% |
| ALINS.PA | Intrasense S.A. | $18.05M | Micro cap | −0.34% |
| BCDA | BioCardia, Inc. | $18.02M | Micro cap | −38.66% |
| CYCN | Cyclerion Therapeutics, Inc. | $17.97M | Micro cap | +61.48% |
| ALTME.PA | TME Pharma N.V. | $17.97M | Micro cap | +25.97% |
| BIVI | BioVie Inc. | $17.83M | Micro cap | +30.25% |
| ALZ.ST | Alzinova AB (publ) | $17.74M | Micro cap | −39.02% |
| 7813.T | Platz Co., Ltd. | $17.74M | Micro cap | +18.51% |
| ABERA.ST | Abera Bioscience AB | $17.69M | Micro cap | +1.61% |
| ADIL | Adial Pharmaceuticals, Inc. | $17.43M | Micro cap | −37.47% |
| HEART.ST | Scandinavian Real Heart AB (Publ) | $17.00M | Micro cap | +3.31% |
| CMMB | Chemomab Therapeutics Ltd. | $16.85M | Micro cap | −25.57% |
| ALEMG.PA | Laboratoires Euromedis Société anonyme | $16.52M | Micro cap | +18.10% |
| 6063.T | Emergency Assistance Japan Co., Ltd. | $15.79M | Micro cap | +0.89% |
| THAT.L | Thalia Therapeutics Plc | $15.69M | Micro cap | +52.94% |
| BTC.AX | BTC Health Limited | $15.67M | Micro cap | −1.61% |
| ADVB | Advanced Biomed Inc. | $15.27M | Micro cap | +13.24% |
| ORTI-B.ST | Ortivus AB (publ) | $15.21M | Micro cap | +42.11% |
| ICR.AX | Intelicare Holdings Limited | $14.91M | Micro cap | +75.76% |
| ACTI.ST | Active Biotech AB (publ) | $14.50M | Micro cap | −62.00% |
| OBSRV.OL | Observe Medical ASA | $14.28M | Micro cap | +5.05% |
| NTI.AX | Neurotech International Limited | $14.26M | Micro cap | +15.38% |
| 189A.T | D&M COMPANY CO LTD | $14.10M | Micro cap | +9.26% |
| 7083.T | AHC Group Inc. | $14.05M | Micro cap | +16.95% |
| PHIO | Phio Pharmaceuticals Corp. | $13.94M | Micro cap | −40.89% |
| IDT.AX | IDT Australia Limited | $13.82M | Micro cap | −30.77% |
| BIOVIC-B.ST | Biovica International AB (publ) | $13.67M | Micro cap | −30.12% |
| SIMRIS-B.ST | Simris Group AB (PUBL) | $13.60M | Micro cap | −28.35% |
| HSCS | HeartSciences Inc. | $13.47M | Micro cap | −11.54% |
| ICO.ST | Iconovo AB (publ) | $12.72M | Micro cap | −52.09% |
| NXTCL.ST | NextCell Pharma AB | $12.42M | Micro cap | −5.10% |
| 6029.T | Artra Group Corporation | $12.41M | Micro cap | −19.57% |
| CRTX.L | CRISM Therapeutics Corporation | $12.38M | Micro cap | +9.52% |
| APRE | Aprea Therapeutics, Inc. | $12.34M | Micro cap | −38.75% |
| ARCOMA.ST | Arcoma AB | $12.17M | Micro cap | −2.13% |
| ALBPS.PA | Biophytis S.A. | $11.98M | Micro cap | −50.31% |
| ASBP | Aspire Biopharma Holdings, Inc. | $11.68M | Micro cap | −60.93% |
| KPRX | Kiora Pharmaceuticals, Inc. | $11.46M | Micro cap | −9.44% |
| TOVX | Theriva Biologics, Inc. | $11.16M | Micro cap | −42.10% |
| ALAMA.PA | AMA Corporation Plc | $10.27M | Micro cap | −34.56% |
| LUCY | Lucyd, Inc | $9.73M | Micro cap | −42.05% |
| IDLDX.ST | IDL Diagnostics AB (publ) | $9.63M | Micro cap | −2.36% |
| MBAI | Check-Cap Ltd. | $9.33M | Micro cap | +943.08% |
| BMGL | Basel Medical Group Ltd | $9.29M | Micro cap | +202.81% |
| IMRN | Immuron Limited | $9.20M | Micro cap | −35.77% |
| XBIO | Xenetic Biosciences, Inc. | $9.04M | Micro cap | +35.92% |
| SKYE | Skye Bioscience, Inc. | $8.92M | Micro cap | −41.62% |
| XWEL | XWELL, Inc. | $8.55M | Micro cap | −6.93% |
| CNSP | CNS Pharmaceuticals, Inc. | $8.48M | Micro cap | −13.51% |
| 7362.T | Terminalcare Support Institute Inc. | $8.43M | Micro cap | +3.53% |
| NEWBRY.ST | Newbury Pharmaceuticals AB (publ) | $8.30M | Micro cap | −0.39% |
| PRE.MI | Predict S.p.A. | $8.17M | Micro cap | +7.51% |
| NDRA | ENDRA Life Sciences Inc. | $8.16M | Micro cap | +32.36% |
| ALZN | Alzamend Neuro, Inc. | $8.06M | Micro cap | −32.11% |
| NVNO | enVVeno Medical Corporation | $7.97M | Micro cap | −63.76% |
| ICCM | IceCure Medical Ltd | $7.85M | Micro cap | +132.49% |
| TRIB | Trinity Biotech plc | $7.80M | Micro cap | +547.97% |
| PILA.ST | Pila Pharma AB (publ) | $7.79M | Micro cap | −15.41% |
| INM | InMed Pharmaceuticals Inc. | $7.64M | Micro cap | −36.44% |
| CODE.OL | CodeLab Capital AS | $7.42M | Micro cap | +22.74% |
| CURX | Curanex Pharmaceuticals Inc | $7.21M | Micro cap | −1.29% |
| 011000.KS | GeneOne Life Science, Inc. | $7.01M | Micro cap | +18.40% |
| IXC.AX | Invex Therapeutics Ltd | $7.00M | Micro cap | +30.00% |
| JUNS | Jupiter Neurosciences, Inc. | $6.66M | Micro cap | +236.24% |
| VBS.AX | Vectus Biosystems Limited | $6.65M | Micro cap | +104.82% |
| MODTX.ST | Modus Therapeutics Holding AB (publ) | $6.35M | Micro cap | −85.49% |
| CTQ.AX | Careteq Limited | $6.32M | Micro cap | +20.00% |
| AMIX | Autonomix Medical, Inc. | $6.20M | Micro cap | +440.68% |
| LIMN | Liminatus Pharma, Inc. | $6.19M | Micro cap | +46.03% |
| PEXA-B.ST | PExA AB (publ) | $6.18M | Micro cap | +79.47% |
| STRAP.CO | Strategic Partners A/S | $5.82M | Micro cap | −28.50% |
| CSCI.TO | COSCIENS Biopharma Inc. | $5.24M | Micro cap | +60.79% |
| SERV.ST | Servana AB | $5.18M | Micro cap | +106.67% |
| FLUI.ST | Fluicell AB (publ) | $5.06M | Micro cap | +247.74% |
| HCWB | HCW Biologics Inc. | $4.96M | Micro cap | −55.15% |
| XAIR | Beyond Air, Inc. | $4.89M | Micro cap | +117.98% |
| GLMD | Galmed Pharmaceuticals Ltd. | $4.48M | Micro cap | +211.51% |
| APS.TO | Aptose Biosciences Inc | $4.41M | Micro cap | +50.00% |
| SILO | Silo Pharma, Inc. | $4.38M | Micro cap | +290.62% |
| AINO.ST | Aino Health AB (publ) | $4.25M | Micro cap | −10.81% |
| ADR.AX | Adherium Limited | $3.93M | Micro cap | +1900.00% |
| DBP-B.ST | Double Bond Pharmaceutical International AB (publ) | $3.53M | Micro cap | +11.79% |
| UPC | Universe Pharmaceuticals INC | $3.53M | Micro cap | +44.57% |
| CLDI | Calidi Biotherapeutics, Inc. | $3.49M | Micro cap | −19.16% |
| TNON | Tenon Medical, Inc. | $3.48M | Micro cap | +297.71% |
| GNPX | Genprex, Inc. | $3.25M | Micro cap | −54.10% |
| PYC.L | Physiomics Plc | $3.17M | Micro cap | +21.18% |
| MONSO.CO | Monsenso A/S | $3.14M | Micro cap | +23.81% |
| SPERM.ST | Spermosens AB (publ) | $3.13M | Micro cap | +15.79% |
| TD1.AX | TALi Digital Limited | $3.02M | Micro cap | −10.00% |
| BIAF | bioAffinity Technologies, Inc. | $3.02M | Micro cap | −31.59% |
| PFSA | Profusa, Inc. | $2.58M | Micro cap | −86.13% |
| VRAX | Virax Biolabs Group Limited | $2.21M | Micro cap | +365.55% |
| PHAL.ST | PharmaLundensis AB | $2.14M | Micro cap | +37.83% |
| SHPH | Shuttle Pharmaceuticals Holdings, Inc. | $2.10M | Micro cap | +7.65% |
| MNDR | Mobile-health Network Solutions | $1.92M | Micro cap | −69.91% |
| RESP.ST | Respiratorius AB (publ) | $1.89M | Micro cap | −39.20% |
| 27N0.DE | Cannovum Cannabis AG | $1.71M | Micro cap | +22.47% |
| BIG1.DE | Bio-Gate AG | $1.55M | Micro cap | +200.53% |
| SCNI | Scinai Immunotherapeutics Ltd. | $1.48M | Micro cap | +93.92% |
| ALINT.PA | IntegraGen SA | $1.38M | Micro cap | −36.25% |
| APM | Aptorum Group Ltd | $570.06K | Micro cap | +273.78% |
| ALNEV.PA | Neovacs S.A. | $22.00 | Micro cap | −11.29% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.